Predictive Value of Serum Mac‐2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus–Infected Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Yun-Chu Chen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Liver Cirrhosis, Antigens, Neoplasm, Membrane Glycoproteins, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Taiwan University Hospital.
Abstract (Originalsprache)
Background
The diagnostic accuracy and optimal cutoff values of serum Mac‐2 binding protein glycosylation isomer (M2BPGi) for predicting hepatic fibrosis severity in hepatitis C virus (HCV)–infected patients with and without metabolic dysfunction–associated steatotic liver disease (MASLD) remain uncertain.
Methods
We recruited 2064 patients with available M2BPGi data and valid vibration‐controlled transient elastography (VCTE) results. The areas under the receiver operating characteristic curves (AUROCs) with 95% confidence intervals (CIs) of M2BPGi were compared between MASLD and non‐MASLD groups for fibrosis stages of ≥F2, ≥F3, and F4. M2BPGi cutoff values were determined for the maximal Youden index, positive likelihood ratio (LR+) nearest to ≥10, and negative LR (LR‐) nearest to ≤0.1.
Results
At the same fibrosis stage, serum M2BPGi levels were significantly higher in MASLD patients than in non‐MASLD patients (F0–F1: 1.12 versus 1.01, p = 0.011; F2: 2.02 versus 1.93, p = 0.013; F3: 3.13 versus 3.08, p = 0.023; F4: 5.32 versus 4.91, p = 0.003). The AUROCs of M2BPGi were comparable between MASLD and non‐MASLD groups for ≥F2 (0.899 [95% CI: 0.878–0.919] versus 0.889 [95% CI: 0.871–0.908]), ≥F3 (0.914 [95% CI: 0.892–0.936] versus 0.934 [95% CI: 0.915–0.952]), and F4 (0.917 [95% CI: 0.894–0.941] versus 0.953 [95% CI: 0.937–0.968]). Optimal cutoff levels for all criteria were higher in patients with MASLD.
Conclusions
Serum M2BPGi is a reliable marker for assessing hepatic fibrosis severity in HCV patients. However, optimal cutoff values should be adjusted according to MASLD status to improve diagnostic accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Biomedical Park Hospital, Hsin-Chu, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
ORCID-Profile: Yun-Chu Chen, Cheng-Yuan Peng, Fu-Jen Lee, Tung-Hung Su, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao, Chen-Hua Liu
Förderung
- National Taiwan University Hospital
Zitieren
APA
Chen, Y. C., Chang, Y. P., Lee, J. Y., Chen, C. Y., Kao, W. Y., Lin, C. L., Yang, S. S., Shih, Y. L., Peng, C. Y., Lee, F. J., Tsai, M. C., Huang, S. C., Su, T. H., Tseng, T. C., Liu, C. J., Chen, P. J., Kao, J. H., & Liu, C. H. (2026). Predictive Value of Serum Mac‐2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus–Infected Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70160
Vancouver
Chen YC, Chang YP, Lee JY, Chen CY, Kao WY, Lin CL, et al. Predictive Value of Serum Mac‐2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus–Infected Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70160
BibTeX
@article{Chen2026,
author = {Chen, Yun-Chu and Chang, Yu-Ping and Lee, Ji-Yuh and Chen, Chi-Yi and Kao, Wei-Yu and Lin, Chih-Lin and Yang, Sheng-Shun and Shih, Yu-Lueng and Peng, Cheng-Yuan and Lee, Fu-Jen and Tsai, Ming-Chang and Huang, Shang-Chin and Su, Tung-Hung and Tseng, Tai-Chung and Liu, Chun-Jen and Chen, Pei-Jer and Kao, Jia-Horng and Liu, Chen-Hua},
title = {Predictive Value of Serum Mac‐2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus–Infected Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70160}
}
EUVIMED